Multidisciplinary treatment of cholangiocarcinoma -impact of induction chemotherapy followed by surgery
Not Applicable
- Conditions
- cholangiocarcinoma
- Registration Number
- JPRN-UMIN000030980
- Lead Sponsor
- Mie University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 143
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients with allergic reaction for TS-1 and gemecitabine 2) patients with severe hepatic disorder (AST or AL: 3 times of normal range or more) 3) patients with severe repeated cholangitis 4) Patients found to be wanting by principal investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival: OS
- Secondary Outcome Measures
Name Time Method progression free survival, safety evaluation, pathological effects of neoadjuvant treatment